iBio is a Texas-based biotechnology company that researches and develops plant-infused therapeutic proteins and vaccines for the treatment of fibrotic diseases...
Read moreiBio is a Texas-based biotechnology company that researches and develops plant-infused therapeutic proteins and vaccines for the treatment of fibrotic diseases...
Read moreAnnual Revenue
$2.3M
iBio's revenue is the ranked 17th among it's top 10 competitors. The top 10 competitors average 23.8B. Over the last two quarters, iBio's revenue has decreased by 96.9%. Specifically, in Q2 2022's revenue was $ < 1M; in Q1 2022, it was $1.9M.